Article Versions Notes

Goutakoli P, Papadaki G, Repa A, Avgoustidis N, Kalogiannaki E, Flouri I, Bertsias A, Zoidakis J, Samiotaki M, Bertsias G, et al. A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells. 2023; 12(24):2808. https://doi.org/10.3390/cells12242808

Goutakoli, Panagiota, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Irini Flouri, Antonios Bertsias, Jerome Zoidakis, Martina Samiotaki, George Bertsias, and et al. 2023. "A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients" Cells 12, no. 24: 2808. https://doi.org/10.3390/cells12242808

Goutakoli, P., Papadaki, G., Repa, A., Avgoustidis, N., Kalogiannaki, E., Flouri, I., Bertsias, A., Zoidakis, J., Samiotaki, M., Bertsias, G., Semitekolou, M., Verginis, P., & Sidiropoulos, P. (2023). A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells, 12(24), 2808. https://doi.org/10.3390/cells12242808